Farshad Guirakhoo

5.7k total citations
67 papers, 4.5k citations indexed

About

Farshad Guirakhoo is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Parasitology. According to data from OpenAlex, Farshad Guirakhoo has authored 67 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Public Health, Environmental and Occupational Health, 54 papers in Infectious Diseases and 16 papers in Parasitology. Recurrent topics in Farshad Guirakhoo's work include Mosquito-borne diseases and control (58 papers), Viral Infections and Vectors (47 papers) and Viral Infections and Outbreaks Research (22 papers). Farshad Guirakhoo is often cited by papers focused on Mosquito-borne diseases and control (58 papers), Viral Infections and Vectors (47 papers) and Viral Infections and Outbreaks Research (22 papers). Farshad Guirakhoo collaborates with scholars based in United States, Austria and France. Farshad Guirakhoo's co-authors include Thomas P. Monath, Franz X. Heinz, Juan Arroyo, К. В. Пугачев, John T. Roehrig, Christian W. Mandl, Heidemarie Holzmann, C Kunz, John Catalan and Richard Nichols and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Virology and Scientific Reports.

In The Last Decade

Farshad Guirakhoo

66 papers receiving 4.3k citations

Peers

Countries citing papers authored by Farshad Guirakhoo

Since Specialization

Citations

This map shows the geographic impact of Farshad Guirakhoo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farshad Guirakhoo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farshad Guirakhoo more than expected).

Fields of papers citing papers by Farshad Guirakhoo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farshad Guirakhoo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farshad Guirakhoo. The network helps show where Farshad Guirakhoo may publish in the future.

Co-authorship network of co-authors of Farshad Guirakhoo

This figure shows the co-authorship network connecting the top 25 collaborators of Farshad Guirakhoo. A scholar is included among the top collaborators of Farshad Guirakhoo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farshad Guirakhoo. Farshad Guirakhoo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A single immunization with a modified vaccinia Ankara vectored vaccine producing Sudan virus-like particles protects from lethal infection 2022 ·npj Vaccines ·Delphine C. Malherbe, Arban Domi, (unknown), Caroline Atyeo, Stephanie Fischinger, (unknown), Julie M. Williams, Galit Alter, Farshad Guirakhoo, Alexander Bukreyev	7
2	A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge 2019 ·Pathogens ·María S. Salvato, Arban Domi, (unknown), Sandra Medina-Moreno, Juan Carlos Zapata, (unknown), Nathanael McCurley, Rahul Basu, (unknown), (unknown), Farshad Guirakhoo	25
3	A Single Dose of Modified Vaccinia Ankara expressing Ebola Virus Like Particles Protects Nonhuman Primates from Lethal Ebola Virus Challenge 2018 ·Scientific Reports ·Arban Domi, Friederike Feldmann, Rahul Basu, Nathanael McCurley, Kyle Shifflett, Jackson Emanuel, (unknown), Farshad Guirakhoo, Chiara Orlandi, Robin Flinko, George K. Lewis, Patrick W. Hanley, Heinz Feldmann, Harriet L. Robinson, Andrea Marzi	33
4	A Zika Vaccine Targeting NS1 Protein Protects Immunocompetent Adult Mice in a Lethal Challenge Model 2017 ·Scientific Reports ·Aaron C. Brault, Arban Domi, Erin McDonald, Dalit Talmi-Frank, Nathanael McCurley, Rahul Basu, Harriet L. Robinson, (unknown), Nisha K. Duggal, Richard A. Bowen, Farshad Guirakhoo	90
5	Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector 2016 ·Clinical and Vaccine Immunology ·Mark R. Schleiss, Ursula Berka, (unknown), (unknown), (unknown), Bastien Mangeat, Elizabeth C. Swanson, (unknown), Nelmary Hernandez-Alvarado, Claudia Fernández-Alarcón, (unknown), Daniel D. Pinschewer, Anders Lilja, Michael G. Schwendinger, Farshad Guirakhoo, Thomas P. Monath, Klaus K. Orlinger	32
6	Direct random insertion of an influenza virus immunologic determinant into the NS1 glycoprotein of a vaccine flavivirus 2009 ·Virology ·Alexander A. Rumyantsev, Zhenxi Zhang, Qingsheng Gao, (unknown), Nathan Brown, Harold Kleanthous, Simon Delagrave, Farshad Guirakhoo, Marc S. Collett, К. В. Пугачев	14
7	A single M protein mutation affects the acid inactivation threshold and growth kinetics of a chimeric flavivirus 2007 ·Virology ·(unknown), Simon Delagrave, Zhenxi Zhang, Nathan Brown, Thomas P. Monath, К. В. Пугачев, Farshad Guirakhoo	13
8	Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE) 2007 ·Vaccine ·К. В. Пугачев, Julia Schwaiger, Nathan Brown, Zhenxi Zhang, John Catalan, (unknown), S. Ocran, Alexander A. Rumyantsev, Alexander A. Khromykh, Thomas P. Monath, Farshad Guirakhoo	10
9	A live, attenuated recombinant West Nile virus vaccine 2006 ·Proceedings of the National Academy of Sciences ·Thomas P. Monath, (unknown), Niranjan Kanesa-thasan, Gwendolyn A. Myers, Richard Nichols, Alison Deary, Karen McCarthy, Casey Johnson, Thomas H. Ermak, Sunheang Shin, Juan Arroyo, Farshad Guirakhoo, Jeffrey S. Kennedy, Francis A. Ennis, Sharone Green, Philip Bedford	155
10	Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All 2006 ·Human Vaccines ·Farshad Guirakhoo, Scott Kitchener, Dennis Morrison, Rémi Forrat, Karen McCarthy, Richard Nichols, Sutee Yoksan, Xiaochu Duan, Thomas H. Ermak, Niranjan Kanesa-thasan, Philip Bedford, Jean Lang, Marie‐José Quentin‐Millet, Thomas P. Monath	155
11	New developments in flavivirus vaccines with special attention to yellow fever 2005 ·Current Opinion in Infectious Diseases ·К. В. Пугачев, Farshad Guirakhoo, Thomas P. Monath	59
12	Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine 2004 ·Vaccine ·David W. C. Beasley, Li Li, Miguel T. Suderman, Farshad Guirakhoo, Dennis W. Trent, Thomas P. Monath, Robert E. Shope, Alan D.T. Barrett	65
13	Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates 2002 ·Virology ·Farshad Guirakhoo, К. В. Пугачев, Juan Arroyo, Catherine Miller, (unknown), Richard Weltzin, (unknown), John Catalan, S. Ocran, Ken Draper, Thomas P. Monath	117
14	West Nile Virus Vaccine. 2001 ·PubMed ·Thomas P. Monath, Juan Arroyo, Catherine Miller, Farshad Guirakhoo	45
15	Phenotypic and Molecular Analyses of Yellow Fever 17DD Vaccine Viruses Associated with Serious Adverse Events in Brazil 2001 ·Virology ·Ricardo Galler, К. В. Пугачев, Cecília L. S. Santos, S. Ocran, Alfredo V. Jabor, (unknown), Renato Sérgio Marchevsky, M.S. Freire, (unknown), Ana Cecília Ribeiro Cruz, (unknown), Iray Maria Rocco, Elizabeth Salbé Travassos da Rosa, Luiza T. M. de Souza, Pedro Fernando da Costa Vasconcelos, Farshad Guirakhoo, Thomas P. Monath	75
16	Immunogenicity, Genetic Stability, and Protective Efficacy of a Recombinant, Chimeric Yellow Fever-Japanese Encephalitis Virus (ChimeriVax-JE) as a Live, Attenuated Vaccine Candidate against Japanese Encephalitis 1999 ·Virology ·Farshad Guirakhoo, (unknown), T J Chambers, Simon Delagrave, Juan Arroyo, Alan D.T. Barrett, Thomas P. Monath	139
17	Effects of humanization by variable domain resurfacing on the antiviral activity of a single-chain antibody against respiratory syncytial virus 1999 ·Protein Engineering Design and Selection ·Simon Delagrave, José Catalán, C. Sweet, (unknown), Alistair J. Henry, Anthony R. Rees, Thomas P. Monath, Farshad Guirakhoo	24
18	Selection and Partial Characterization of Dengue 2 Virus Mutants That Induce Fusion at Elevated pH 1993 ·Virology ·Farshad Guirakhoo, Ann R. Hunt, (unknown), John T. Roehrig	87
19	The relationship between the flaviviruses Skalica and Langat as revealed by monoclonal antibodies, peptide mapping and RNA sequence analysis 1991 ·Journal of General Virology ·Farshad Guirakhoo, Franz X. Heinz, Christian W. Mandl, (unknown), C Kunz, M Greśíková	5
20	Characterization of Antigenic Variants of Tick-borne Encephalitis Virus Selected with Neutralizing Monoclonal Antibodies 1989 ·Journal of General Virology ·(unknown), Christian W. Mandl, Farshad Guirakhoo, Franz X. Heinz, C Kunz	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact